Global Tumor-Infiltrating Lymphocyte Therapy Market Growth (Status and Outlook) 2026-2032
The global Tumor-Infiltrating Lymphocyte Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Tumor-Infiltrating Lymphocyte therapy is a form of adoptive cell therapy used in cancer treatment that harnesses the patient’s own immune cells to fight tumors. TILs are a type of immune cell that naturally penetrate tumor tissues. In TIL therapy, these lymphocytes are extracted from the patient's tumor, expanded in large numbers in a laboratory, and then reintroduced into the patient after the tumor has been reduced or suppressed, typically following lymphodepleting chemotherapy.TIL therapy has shown promise particularly in the treatment of melanoma and other solid tumors.
United States market for Tumor-Infiltrating Lymphocyte Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor-Infiltrating Lymphocyte Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor-Infiltrating Lymphocyte Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor-Infiltrating Lymphocyte Therapy players cover Iovance Biotherapeutics, Moffitt Cancer Center, Essen Biotech, Turnstone Biologics, Obsidian Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Tumor-Infiltrating Lymphocyte Therapy Industry Forecast” looks at past sales and reviews total world Tumor-Infiltrating Lymphocyte Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor-Infiltrating Lymphocyte Therapy sales for 2026 through 2032. With Tumor-Infiltrating Lymphocyte Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor-Infiltrating Lymphocyte Therapy industry.
This Insight Report provides a comprehensive analysis of the global Tumor-Infiltrating Lymphocyte Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor-Infiltrating Lymphocyte Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor-Infiltrating Lymphocyte Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor-Infiltrating Lymphocyte Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor-Infiltrating Lymphocyte Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor-Infiltrating Lymphocyte Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
The report requires updating with new data and is sent in 48 hours after order is placed.
Tumor-Infiltrating Lymphocyte therapy is a form of adoptive cell therapy used in cancer treatment that harnesses the patient’s own immune cells to fight tumors. TILs are a type of immune cell that naturally penetrate tumor tissues. In TIL therapy, these lymphocytes are extracted from the patient's tumor, expanded in large numbers in a laboratory, and then reintroduced into the patient after the tumor has been reduced or suppressed, typically following lymphodepleting chemotherapy.TIL therapy has shown promise particularly in the treatment of melanoma and other solid tumors.
United States market for Tumor-Infiltrating Lymphocyte Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Tumor-Infiltrating Lymphocyte Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Tumor-Infiltrating Lymphocyte Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Tumor-Infiltrating Lymphocyte Therapy players cover Iovance Biotherapeutics, Moffitt Cancer Center, Essen Biotech, Turnstone Biologics, Obsidian Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Tumor-Infiltrating Lymphocyte Therapy Industry Forecast” looks at past sales and reviews total world Tumor-Infiltrating Lymphocyte Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Tumor-Infiltrating Lymphocyte Therapy sales for 2026 through 2032. With Tumor-Infiltrating Lymphocyte Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor-Infiltrating Lymphocyte Therapy industry.
This Insight Report provides a comprehensive analysis of the global Tumor-Infiltrating Lymphocyte Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor-Infiltrating Lymphocyte Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor-Infiltrating Lymphocyte Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor-Infiltrating Lymphocyte Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor-Infiltrating Lymphocyte Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor-Infiltrating Lymphocyte Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Combined with IL-2
- Not Combined with IL-2
- Melanoma
- Cervical Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Iovance Biotherapeutics
- Moffitt Cancer Center
- Essen Biotech
- Turnstone Biologics
- Obsidian Therapeutics
- Hervor Therapeutics
- Intima Bioscience
- Instil Bio
- Shanghai Juncell Therapeutics
- Suzhou BlueHorse Therapeutics
- Grit Biotechnology
- TCRCure Biopharma
- BioSyngen
- Sino-Cell Biomed
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size (2021-2032)
2.1.2 Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tumor-Infiltrating Lymphocyte Therapy by Country/Region (2021, 2025 & 2032)
2.2 Tumor-Infiltrating Lymphocyte Therapy Segment by Type
2.2.1 Combined with IL-2
2.2.2 Not Combined with IL-2
2.2.3 Tumor-Infiltrating Lymphocyte Therapy Market Size by Type
2.2.3.1 Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
2.3 Tumor-Infiltrating Lymphocyte Therapy Segment by Application
2.3.1 Melanoma
2.3.2 Cervical Cancer
2.3.3 Others
2.3.4 Tumor-Infiltrating Lymphocyte Therapy Market Size by Application
2.3.4.1 Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
3 TUMOR-INFILTRATING LYMPHOCYTE THERAPY MARKET SIZE BY PLAYER
3.1 Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Player
3.1.1 Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Player (2021-2026)
3.1.2 Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Tumor-Infiltrating Lymphocyte Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR-INFILTRATING LYMPHOCYTE THERAPY BY REGION
4.1 Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026)
4.2 Global Tumor-Infiltrating Lymphocyte Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor-Infiltrating Lymphocyte Therapy Market Size Growth (2021-2026)
4.4 APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Growth (2021-2026)
4.5 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021-2026)
5.2 Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026)
5.3 Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026)
6.2 APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026)
6.3 APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021-2026)
7.2 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026)
7.3 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy by Region (2021-2026)
8.2 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR-INFILTRATING LYMPHOCYTE THERAPY MARKET FORECAST
10.1 Global Tumor-Infiltrating Lymphocyte Therapy Forecast by Region (2027-2032)
10.1.1 Global Tumor-Infiltrating Lymphocyte Therapy Forecast by Region (2027-2032)
10.1.2 Americas Tumor-Infiltrating Lymphocyte Therapy Forecast
10.1.3 APAC Tumor-Infiltrating Lymphocyte Therapy Forecast
10.1.4 Europe Tumor-Infiltrating Lymphocyte Therapy Forecast
10.1.5 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Forecast
10.2 Americas Tumor-Infiltrating Lymphocyte Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.2.2 Canada Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.2.3 Mexico Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.2.4 Brazil Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3 APAC Tumor-Infiltrating Lymphocyte Therapy Forecast by Region (2027-2032)
10.3.1 China Tumor-Infiltrating Lymphocyte Therapy Market Forecast
10.3.2 Japan Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3.3 Korea Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3.4 Southeast Asia Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3.5 India Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3.6 Australia Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4 Europe Tumor-Infiltrating Lymphocyte Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4.2 France Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4.3 UK Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4.4 Italy Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4.5 Russia Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.5 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.5.2 South Africa Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.5.3 Israel Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.5.4 Turkey Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.6 Global Tumor-Infiltrating Lymphocyte Therapy Forecast by Type (2027-2032)
10.7 Global Tumor-Infiltrating Lymphocyte Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tumor-Infiltrating Lymphocyte Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Iovance Biotherapeutics
11.1.1 Iovance Biotherapeutics Company Information
11.1.2 Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.1.3 Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Iovance Biotherapeutics Main Business Overview
11.1.5 Iovance Biotherapeutics Latest Developments
11.2 Moffitt Cancer Center
11.2.1 Moffitt Cancer Center Company Information
11.2.2 Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.2.3 Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Moffitt Cancer Center Main Business Overview
11.2.5 Moffitt Cancer Center Latest Developments
11.3 Essen Biotech
11.3.1 Essen Biotech Company Information
11.3.2 Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.3.3 Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Essen Biotech Main Business Overview
11.3.5 Essen Biotech Latest Developments
11.4 Turnstone Biologics
11.4.1 Turnstone Biologics Company Information
11.4.2 Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.4.3 Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Turnstone Biologics Main Business Overview
11.4.5 Turnstone Biologics Latest Developments
11.5 Obsidian Therapeutics
11.5.1 Obsidian Therapeutics Company Information
11.5.2 Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.5.3 Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Obsidian Therapeutics Main Business Overview
11.5.5 Obsidian Therapeutics Latest Developments
11.6 Hervor Therapeutics
11.6.1 Hervor Therapeutics Company Information
11.6.2 Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.6.3 Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Hervor Therapeutics Main Business Overview
11.6.5 Hervor Therapeutics Latest Developments
11.7 Intima Bioscience
11.7.1 Intima Bioscience Company Information
11.7.2 Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.7.3 Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Intima Bioscience Main Business Overview
11.7.5 Intima Bioscience Latest Developments
11.8 Instil Bio
11.8.1 Instil Bio Company Information
11.8.2 Instil Bio Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.8.3 Instil Bio Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Instil Bio Main Business Overview
11.8.5 Instil Bio Latest Developments
11.9 Shanghai Juncell Therapeutics
11.9.1 Shanghai Juncell Therapeutics Company Information
11.9.2 Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.9.3 Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Shanghai Juncell Therapeutics Main Business Overview
11.9.5 Shanghai Juncell Therapeutics Latest Developments
11.10 Suzhou BlueHorse Therapeutics
11.10.1 Suzhou BlueHorse Therapeutics Company Information
11.10.2 Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.10.3 Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Suzhou BlueHorse Therapeutics Main Business Overview
11.10.5 Suzhou BlueHorse Therapeutics Latest Developments
11.11 Grit Biotechnology
11.11.1 Grit Biotechnology Company Information
11.11.2 Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.11.3 Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Grit Biotechnology Main Business Overview
11.11.5 Grit Biotechnology Latest Developments
11.12 TCRCure Biopharma
11.12.1 TCRCure Biopharma Company Information
11.12.2 TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.12.3 TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 TCRCure Biopharma Main Business Overview
11.12.5 TCRCure Biopharma Latest Developments
11.13 BioSyngen
11.13.1 BioSyngen Company Information
11.13.2 BioSyngen Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.13.3 BioSyngen Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 BioSyngen Main Business Overview
11.13.5 BioSyngen Latest Developments
11.14 Sino-Cell Biomed
11.14.1 Sino-Cell Biomed Company Information
11.14.2 Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.14.3 Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Sino-Cell Biomed Main Business Overview
11.14.5 Sino-Cell Biomed Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size (2021-2032)
2.1.2 Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tumor-Infiltrating Lymphocyte Therapy by Country/Region (2021, 2025 & 2032)
2.2 Tumor-Infiltrating Lymphocyte Therapy Segment by Type
2.2.1 Combined with IL-2
2.2.2 Not Combined with IL-2
2.2.3 Tumor-Infiltrating Lymphocyte Therapy Market Size by Type
2.2.3.1 Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
2.3 Tumor-Infiltrating Lymphocyte Therapy Segment by Application
2.3.1 Melanoma
2.3.2 Cervical Cancer
2.3.3 Others
2.3.4 Tumor-Infiltrating Lymphocyte Therapy Market Size by Application
2.3.4.1 Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
3 TUMOR-INFILTRATING LYMPHOCYTE THERAPY MARKET SIZE BY PLAYER
3.1 Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Player
3.1.1 Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Player (2021-2026)
3.1.2 Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Tumor-Infiltrating Lymphocyte Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUMOR-INFILTRATING LYMPHOCYTE THERAPY BY REGION
4.1 Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026)
4.2 Global Tumor-Infiltrating Lymphocyte Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tumor-Infiltrating Lymphocyte Therapy Market Size Growth (2021-2026)
4.4 APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Growth (2021-2026)
4.5 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021-2026)
5.2 Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026)
5.3 Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026)
6.2 APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026)
6.3 APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021-2026)
7.2 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026)
7.3 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy by Region (2021-2026)
8.2 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUMOR-INFILTRATING LYMPHOCYTE THERAPY MARKET FORECAST
10.1 Global Tumor-Infiltrating Lymphocyte Therapy Forecast by Region (2027-2032)
10.1.1 Global Tumor-Infiltrating Lymphocyte Therapy Forecast by Region (2027-2032)
10.1.2 Americas Tumor-Infiltrating Lymphocyte Therapy Forecast
10.1.3 APAC Tumor-Infiltrating Lymphocyte Therapy Forecast
10.1.4 Europe Tumor-Infiltrating Lymphocyte Therapy Forecast
10.1.5 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Forecast
10.2 Americas Tumor-Infiltrating Lymphocyte Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.2.2 Canada Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.2.3 Mexico Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.2.4 Brazil Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3 APAC Tumor-Infiltrating Lymphocyte Therapy Forecast by Region (2027-2032)
10.3.1 China Tumor-Infiltrating Lymphocyte Therapy Market Forecast
10.3.2 Japan Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3.3 Korea Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3.4 Southeast Asia Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3.5 India Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.3.6 Australia Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4 Europe Tumor-Infiltrating Lymphocyte Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4.2 France Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4.3 UK Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4.4 Italy Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.4.5 Russia Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.5 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.5.2 South Africa Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.5.3 Israel Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.5.4 Turkey Market Tumor-Infiltrating Lymphocyte Therapy Forecast
10.6 Global Tumor-Infiltrating Lymphocyte Therapy Forecast by Type (2027-2032)
10.7 Global Tumor-Infiltrating Lymphocyte Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tumor-Infiltrating Lymphocyte Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Iovance Biotherapeutics
11.1.1 Iovance Biotherapeutics Company Information
11.1.2 Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.1.3 Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Iovance Biotherapeutics Main Business Overview
11.1.5 Iovance Biotherapeutics Latest Developments
11.2 Moffitt Cancer Center
11.2.1 Moffitt Cancer Center Company Information
11.2.2 Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.2.3 Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Moffitt Cancer Center Main Business Overview
11.2.5 Moffitt Cancer Center Latest Developments
11.3 Essen Biotech
11.3.1 Essen Biotech Company Information
11.3.2 Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.3.3 Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Essen Biotech Main Business Overview
11.3.5 Essen Biotech Latest Developments
11.4 Turnstone Biologics
11.4.1 Turnstone Biologics Company Information
11.4.2 Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.4.3 Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Turnstone Biologics Main Business Overview
11.4.5 Turnstone Biologics Latest Developments
11.5 Obsidian Therapeutics
11.5.1 Obsidian Therapeutics Company Information
11.5.2 Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.5.3 Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Obsidian Therapeutics Main Business Overview
11.5.5 Obsidian Therapeutics Latest Developments
11.6 Hervor Therapeutics
11.6.1 Hervor Therapeutics Company Information
11.6.2 Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.6.3 Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Hervor Therapeutics Main Business Overview
11.6.5 Hervor Therapeutics Latest Developments
11.7 Intima Bioscience
11.7.1 Intima Bioscience Company Information
11.7.2 Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.7.3 Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Intima Bioscience Main Business Overview
11.7.5 Intima Bioscience Latest Developments
11.8 Instil Bio
11.8.1 Instil Bio Company Information
11.8.2 Instil Bio Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.8.3 Instil Bio Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Instil Bio Main Business Overview
11.8.5 Instil Bio Latest Developments
11.9 Shanghai Juncell Therapeutics
11.9.1 Shanghai Juncell Therapeutics Company Information
11.9.2 Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.9.3 Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Shanghai Juncell Therapeutics Main Business Overview
11.9.5 Shanghai Juncell Therapeutics Latest Developments
11.10 Suzhou BlueHorse Therapeutics
11.10.1 Suzhou BlueHorse Therapeutics Company Information
11.10.2 Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.10.3 Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Suzhou BlueHorse Therapeutics Main Business Overview
11.10.5 Suzhou BlueHorse Therapeutics Latest Developments
11.11 Grit Biotechnology
11.11.1 Grit Biotechnology Company Information
11.11.2 Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.11.3 Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Grit Biotechnology Main Business Overview
11.11.5 Grit Biotechnology Latest Developments
11.12 TCRCure Biopharma
11.12.1 TCRCure Biopharma Company Information
11.12.2 TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.12.3 TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 TCRCure Biopharma Main Business Overview
11.12.5 TCRCure Biopharma Latest Developments
11.13 BioSyngen
11.13.1 BioSyngen Company Information
11.13.2 BioSyngen Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.13.3 BioSyngen Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 BioSyngen Main Business Overview
11.13.5 BioSyngen Latest Developments
11.14 Sino-Cell Biomed
11.14.1 Sino-Cell Biomed Company Information
11.14.2 Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Product Offered
11.14.3 Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Sino-Cell Biomed Main Business Overview
11.14.5 Sino-Cell Biomed Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tumor-Infiltrating Lymphocyte Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Combined with IL-2
Table 4. Major Players of Not Combined with IL-2
Table 5. Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Table 8. Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Player (2021-2026)
Table 13. Tumor-Infiltrating Lymphocyte Therapy Key Players Head office and Products Offered
Table 14. Tumor-Infiltrating Lymphocyte Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Tumor-Infiltrating Lymphocyte Therapy
Table 39. Key Market Challenges & Risks of Tumor-Infiltrating Lymphocyte Therapy
Table 40. Key Industry Trends of Tumor-Infiltrating Lymphocyte Therapy
Table 41. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Iovance Biotherapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 46. Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 47. Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Iovance Biotherapeutics Main Business
Table 49. Iovance Biotherapeutics Latest Developments
Table 50. Moffitt Cancer Center Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 51. Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 52. Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Moffitt Cancer Center Main Business
Table 54. Moffitt Cancer Center Latest Developments
Table 55. Essen Biotech Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 56. Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 57. Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Essen Biotech Main Business
Table 59. Essen Biotech Latest Developments
Table 60. Turnstone Biologics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 61. Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 62. Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Turnstone Biologics Main Business
Table 64. Turnstone Biologics Latest Developments
Table 65. Obsidian Therapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 66. Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 67. Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Obsidian Therapeutics Main Business
Table 69. Obsidian Therapeutics Latest Developments
Table 70. Hervor Therapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 71. Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 72. Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Hervor Therapeutics Main Business
Table 74. Hervor Therapeutics Latest Developments
Table 75. Intima Bioscience Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 76. Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 77. Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Intima Bioscience Main Business
Table 79. Intima Bioscience Latest Developments
Table 80. Instil Bio Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 81. Instil Bio Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 82. Instil Bio Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Instil Bio Main Business
Table 84. Instil Bio Latest Developments
Table 85. Shanghai Juncell Therapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 86. Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 87. Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Shanghai Juncell Therapeutics Main Business
Table 89. Shanghai Juncell Therapeutics Latest Developments
Table 90. Suzhou BlueHorse Therapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 91. Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 92. Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Suzhou BlueHorse Therapeutics Main Business
Table 94. Suzhou BlueHorse Therapeutics Latest Developments
Table 95. Grit Biotechnology Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 96. Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 97. Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Grit Biotechnology Main Business
Table 99. Grit Biotechnology Latest Developments
Table 100. TCRCure Biopharma Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 101. TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 102. TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. TCRCure Biopharma Main Business
Table 104. TCRCure Biopharma Latest Developments
Table 105. BioSyngen Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 106. BioSyngen Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 107. BioSyngen Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. BioSyngen Main Business
Table 109. BioSyngen Latest Developments
Table 110. Sino-Cell Biomed Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 111. Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 112. Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Sino-Cell Biomed Main Business
Table 114. Sino-Cell Biomed Latest Developments
Table 1. Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tumor-Infiltrating Lymphocyte Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Combined with IL-2
Table 4. Major Players of Not Combined with IL-2
Table 5. Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Table 8. Tumor-Infiltrating Lymphocyte Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Player (2021-2026)
Table 13. Tumor-Infiltrating Lymphocyte Therapy Key Players Head office and Products Offered
Table 14. Tumor-Infiltrating Lymphocyte Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Tumor-Infiltrating Lymphocyte Therapy
Table 39. Key Market Challenges & Risks of Tumor-Infiltrating Lymphocyte Therapy
Table 40. Key Industry Trends of Tumor-Infiltrating Lymphocyte Therapy
Table 41. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Iovance Biotherapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 46. Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 47. Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Iovance Biotherapeutics Main Business
Table 49. Iovance Biotherapeutics Latest Developments
Table 50. Moffitt Cancer Center Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 51. Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 52. Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Moffitt Cancer Center Main Business
Table 54. Moffitt Cancer Center Latest Developments
Table 55. Essen Biotech Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 56. Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 57. Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Essen Biotech Main Business
Table 59. Essen Biotech Latest Developments
Table 60. Turnstone Biologics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 61. Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 62. Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Turnstone Biologics Main Business
Table 64. Turnstone Biologics Latest Developments
Table 65. Obsidian Therapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 66. Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 67. Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Obsidian Therapeutics Main Business
Table 69. Obsidian Therapeutics Latest Developments
Table 70. Hervor Therapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 71. Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 72. Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Hervor Therapeutics Main Business
Table 74. Hervor Therapeutics Latest Developments
Table 75. Intima Bioscience Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 76. Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 77. Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Intima Bioscience Main Business
Table 79. Intima Bioscience Latest Developments
Table 80. Instil Bio Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 81. Instil Bio Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 82. Instil Bio Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Instil Bio Main Business
Table 84. Instil Bio Latest Developments
Table 85. Shanghai Juncell Therapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 86. Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 87. Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Shanghai Juncell Therapeutics Main Business
Table 89. Shanghai Juncell Therapeutics Latest Developments
Table 90. Suzhou BlueHorse Therapeutics Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 91. Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 92. Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Suzhou BlueHorse Therapeutics Main Business
Table 94. Suzhou BlueHorse Therapeutics Latest Developments
Table 95. Grit Biotechnology Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 96. Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 97. Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Grit Biotechnology Main Business
Table 99. Grit Biotechnology Latest Developments
Table 100. TCRCure Biopharma Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 101. TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 102. TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. TCRCure Biopharma Main Business
Table 104. TCRCure Biopharma Latest Developments
Table 105. BioSyngen Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 106. BioSyngen Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 107. BioSyngen Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. BioSyngen Main Business
Table 109. BioSyngen Latest Developments
Table 110. Sino-Cell Biomed Details, Company Type, Tumor-Infiltrating Lymphocyte Therapy Area Served and Its Competitors
Table 111. Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Product Offered
Table 112. Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Sino-Cell Biomed Main Business
Table 114. Sino-Cell Biomed Latest Developments
LIST OF FIGURES
Figure 1. Tumor-Infiltrating Lymphocyte Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tumor-Infiltrating Lymphocyte Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tumor-Infiltrating Lymphocyte Therapy Sales Market Share by Country/Region (2025)
Figure 8. Tumor-Infiltrating Lymphocyte Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type in 2025
Figure 10. Tumor-Infiltrating Lymphocyte Therapy in Melanoma
Figure 11. Global Tumor-Infiltrating Lymphocyte Therapy Market: Melanoma (2021-2026) & ($ millions)
Figure 12. Tumor-Infiltrating Lymphocyte Therapy in Cervical Cancer
Figure 13. Global Tumor-Infiltrating Lymphocyte Therapy Market: Cervical Cancer (2021-2026) & ($ millions)
Figure 14. Tumor-Infiltrating Lymphocyte Therapy in Others
Figure 15. Global Tumor-Infiltrating Lymphocyte Therapy Market: Others (2021-2026) & ($ millions)
Figure 16. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application in 2025
Figure 17. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Player in 2025
Figure 18. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region (2021-2026)
Figure 19. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size 2021-2026 ($ millions)
Figure 20. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size 2021-2026 ($ millions)
Figure 21. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size 2021-2026 ($ millions)
Figure 23. Americas Tumor-Infiltrating Lymphocyte Therapy Value Market Share by Country in 2025
Figure 24. United States Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region in 2025
Figure 29. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Figure 30. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Figure 31. China Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. India Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Country in 2025
Figure 38. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Figure 39. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Figure 40. Germany Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. France Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 54. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 55. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 57. United States Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 58. Canada Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 59. Mexico Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 60. Brazil Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 61. China Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 62. Japan Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 63. Korea Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 65. India Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 66. Australia Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 67. Germany Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 68. France Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 69. UK Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 70. Italy Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 71. Russia Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 72. Egypt Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 73. South Africa Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 74. Israel Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 75. Turkey Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 76. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 1. Tumor-Infiltrating Lymphocyte Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tumor-Infiltrating Lymphocyte Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tumor-Infiltrating Lymphocyte Therapy Sales Market Share by Country/Region (2025)
Figure 8. Tumor-Infiltrating Lymphocyte Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type in 2025
Figure 10. Tumor-Infiltrating Lymphocyte Therapy in Melanoma
Figure 11. Global Tumor-Infiltrating Lymphocyte Therapy Market: Melanoma (2021-2026) & ($ millions)
Figure 12. Tumor-Infiltrating Lymphocyte Therapy in Cervical Cancer
Figure 13. Global Tumor-Infiltrating Lymphocyte Therapy Market: Cervical Cancer (2021-2026) & ($ millions)
Figure 14. Tumor-Infiltrating Lymphocyte Therapy in Others
Figure 15. Global Tumor-Infiltrating Lymphocyte Therapy Market: Others (2021-2026) & ($ millions)
Figure 16. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application in 2025
Figure 17. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Player in 2025
Figure 18. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region (2021-2026)
Figure 19. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size 2021-2026 ($ millions)
Figure 20. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size 2021-2026 ($ millions)
Figure 21. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size 2021-2026 ($ millions)
Figure 23. Americas Tumor-Infiltrating Lymphocyte Therapy Value Market Share by Country in 2025
Figure 24. United States Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region in 2025
Figure 29. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Figure 30. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Figure 31. China Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. India Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Country in 2025
Figure 38. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Figure 39. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Figure 40. Germany Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. France Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Tumor-Infiltrating Lymphocyte Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 54. APAC Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 55. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 57. United States Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 58. Canada Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 59. Mexico Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 60. Brazil Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 61. China Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 62. Japan Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 63. Korea Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 65. India Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 66. Australia Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 67. Germany Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 68. France Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 69. UK Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 70. Italy Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 71. Russia Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 72. Egypt Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 73. South Africa Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 74. Israel Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 75. Turkey Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
Figure 76. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Tumor-Infiltrating Lymphocyte Therapy Market Size 2027-2032 ($ millions)
